Question 1

PFE vs RARE: which stock scores better overall?

Accepted Answer

Based on Q·Score, Pfizer, Inc. (PFE) scores 6.5/10 versus Ultragenyx Pharmaceutical Inc. (RARE) at 5.2/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: PFE or RARE?

Accepted Answer

Ultragenyx Pharmaceutical Inc. (RARE) scores higher on Growth (6.5/10 vs 5.6/10). Pfizer, Inc. reports revenue growth (-1.2% YoY) while Ultragenyx Pharmaceutical Inc. reports (25.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is PFE or RARE more attractively valued?

Accepted Answer

Ultragenyx Pharmaceutical Inc. (RARE) scores higher on Value (6.9/10 vs 6.7/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about PFE vs RARE?

Accepted Answer

There are 27 analysts covering PFE with a consensus price target of $29.00, and 20 analysts covering RARE with a consensus target of $53.35. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: PFE or RARE?

Accepted Answer

Pfizer, Inc. (PFE) scores higher on Quality (7.4/10 vs 0.2/10). Net profit margin: PFE at 12.4%, RARE at -85.4%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: PFE or RARE?

Accepted Answer

Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 5.9/10). Market beta: PFE at 0.39, RARE at 0.25. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of PFE and RARE?

Accepted Answer

Pfizer, Inc. (PFE) has a market capitalisation of $149.8B, while Ultragenyx Pharmaceutical Inc. (RARE) has a market cap of $2.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do PFE or RARE pay dividends?

Accepted Answer

PFE pays a dividend yield of 6.53%, while RARE does not currently pay a dividend. Dividend yields fluctuate with share price and company payout decisions.

Pfizer, Inc. vs Ultragenyx Pharmaceutical Inc. — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals